07.02.2018 • News

IGP Methanol Awards Contracts for US Complex

IGP Methanol has awarded engineering and technology contracts to CB&I and...
IGP Methanol has awarded engineering and technology contracts to CB&I and Haldor Topsoe for its proposed methanol complex on the US Gulf Coast (c) CB&I

IGP Methanol has awarded engineering and technology contracts to CB&I and Haldor Topsoe for its proposed methanol complex on the US Gulf Coast.

US contractor CB&I will provide front-end engineering services (FEED) to produce a binding lump sum price for the complex in Myrtle Grove, Louisiana. The facility will comprise four identical methanol trains, each with a capacity of 1.8 million t/y, as well as associated facilities. The FEED contract also includes terms for the exclusive selection of CB&I for the engineering, procurement and construction of each of the four trains.

In addition, Danish catalysis and processing engineering company Haldor Topsoe will provide its SynCor reforming technology for the project. James Lamoreaux, IGP Methanol’s managing director, said Topsoe’s SynCor technology offers high single-line capacity with the lowest emission per ton of methanol produced along with unrivalled economies of scale.

On Jan. 4, the Louisiana Department of Environmental Quality issued an air-quality operating permit for the 7.2 million t/y complex, which IGP says will be the world's largest methanol plant when its starts production in late 2020.

Other companies collaborating on the project are ConocoPhillips, which will provide natural gas supply and supply management services; Praxair, which will build, own, operate and maintain the air-separation units; Veolia, which will build and operate the complex’s water treatment and wastewater plant; and Entergy Corp., which will build a dedicated electrical substation at the site.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read